10 May 2018 by admin in UncategorizedComments Syros Reports First Quarter 2018 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
09 May 2018 by admin in UncategorizedComments resTORbio Completes Dosing of Patients in Phase 2b Study to Reduce the Incidence of Respiratory Tract Infections in the Elderly
30 Apr 2018 by admin in UncategorizedComments Crescendo Biologics Ltd. Raises $70 Million (€57 Million) in Series B Financing
29 Mar 2018 by admin in UncategorizedComments resTORbio Reports Fourth Quarter and Full Year 2017 Financial Results
29 Mar 2018 by admin in UncategorizedComments ARMO BioSciences Enrolls First Patient in the CYPRESS 2 Trial Evaluating AM0010 in Non-Small Cell Lung Cancer
28 Mar 2018 by admin in UncategorizedComments Tempest Therapeutics Closes $70 Million Series B Financing – Cancer immunology programs launched from Versant’s Inception Discovery Engine –
